TABLE 4.
HBGA recognition predicted by carbohydrate- and saliva-VLP binding assay
| Genogroup | Genotype | VLP | Binding assay result
|
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Saliva-VLP
|
Carbohydrate-VLPb
|
|||||||||||
| H | A | B | Lea | Leb | H type 1/2/3 | Tri-A | Tri-B | Lea | Leb | |||
| GI | 1 | r124 | + | + | − | NDa | ND | + | + | − | − | + |
| 2 | r258 | + | + | − | ND | ND | + | + | − | + | − | |
| 3 | r645 | + | + | − | ND | ND | + | + | − | + | − | |
| 4 | rCV | + | + | − | ND | ND | − | + | − | + | + | |
| 8 | rW18 | + | + | + | ND | ND | − | + | + | + | + | |
| GII | 1 | r485 | − | − | − | ND | ND | − | − | − | − | − |
| 1 | rHV | − | − | − | ND | ND | − | − | − | − | − | |
| 3 | r18-3 | − | + | + | ND | ND | + | − | − | − | − | |
| 3 | r336 | − | + | + | ND | ND | + | − | − | − | − | |
| 4 | r104 | + | + | + | ND | ND | + | + | + | − | + | |
| 5 | r754 | − | + | + | ND | ND | − | + | + | − | − | |
| 6 | r7k | + | + | + | ND | ND | + | − | + | + | + | |
| 6 | r445 | + | + | + | ND | ND | + | − | − | − | − | |
| 7 | r10-25 | + | + | + | ND | ND | + | − | + | + | + | |
| 12 | r76 | − | − | + | ND | ND | − | − | − | − | − | |
| 14 | r47 | − | − | − | ND | ND | − | − | − | − | − | |
a
ND, not clarified by the saliva-VLP binding assay.
b
Relative optical densities (optical density at 492 nm/internal standard) greater than 0.178 were considered positive in the carbohydrate-VLP binding assay.